Application 019845
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BETOPTIC S | BETAXOLOL HYDROCHLORIDE | SUSPENSION/DROPS;OPHTHALMIC | EQ 0.25% BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019845-001 | BETOPTIC S | BETAXOLOL HYDROCHLORIDE | EQ 0.25% BASE | SUSPENSION/DROPS / OPHTHALMIC | RLD, RS | 1989-12-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N019845-001 | BETOPTIC S | EQ 0.25% BASE | SUSPENSION/DROPS / OPHTHALMIC | RLD, RS | 1989-12-29 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N019845-001 | BETOPTIC S | EQ 0.25% BASE | SUSPENSION/DROPS / OPHTHALMIC | RLD, RS | 1989-12-29 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N019845-001 | BETOPTIC S | EQ 0.25% BASE | SUSPENSION/DROPS / OPHTHALMIC | RLD, RS | 1989-12-29 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N019845-001 | BETOPTIC S | EQ 0.25% BASE | SUSPENSION/DROPS / OPHTHALMIC | RLD, RS | 1989-12-29 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betoptic S | BETAXOLOL HYDROCHLORIDE | Novartis Pharmaceuticals Corporation | 905ba189-456c-4aa4-8231-39a971374ad8 | 2025-01-22 | Warnings, Adverse reactions | 019845 NDA019845 0078-0729 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0065-0246 | Betoptic S | betaxolol hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0246 | Betoptic S | betaxolol hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0246 | Betoptic S | betaxolol hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0246 | Betoptic S | betaxolol hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0246 | Betoptic S | betaxolol hydrochloride | Alcon Laboratories, Inc. | NDA | Current |
| 0078-0729 | Betoptic S | betaxolol hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 67763 | SUPPL | 2021-06-11 |
| 67754 | SUPPL | 2021-06-10 |
| 47102 | SUPPL | 2017-02-06 |
| 47087 | SUPPL | 2017-02-01 |
| 47080 | SUPPL | 2017-01-31 |
| 11767 | SUPPL | 2008-06-12 |
| 19742 | SUPPL | 2008-05-14 |
| 19741 | SUPPL | 2007-06-14 |
| 34015 | SUPPL | 2007-06-12 |
| 19291 | SUPPL | 2003-06-08 |
| 11766 | SUPPL | 2003-05-29 |
| 53082 | SUPPL | 1900-01-01 |
| 53081 | SUPPL | 1900-01-01 |
| 51784 | SUPPL | 1900-01-01 |